Filters
In the final analysis of the real-world PEARL study presented at EAN 2025, fremanezumab as a preventive treatment for chronic or episodic migraine halves the number of monthly migraine days or more from 3 months onwards through 24 months
The novel selective orexin-2 receptor (OX2R) antagonist seltorexant helped promote sleep in people with insomnia, with the efficacy maintained over a 2-week treatment period, according to a phase 2b study.
Women with prenatal exposure to selective serotonin and serotonin-norepinephrine reuptake inhibitors (SSRIs and SNRIs) are at increased risk of postpartum haemorrhage (PPH), although residual confounding cannot be ruled out, as reported in a study.
The use of oseltamivir for treating influenza episodes in children appears to lower the risk of serious neuropsychiatric events, according to a retrospective cohort study.
Pregnancy loss is devastating to any couple, and such an experience may result in depression, stress, and anxiety, particularly among women.
Among patients receiving treatment for schizophrenia, infections appear to occur at a higher rate with clozapine vs olanzapine, as shown in a study from Hong Kong.
People with multiple sclerosis (MS) tend to experience a lower sexual function (SF) than healthy individuals, reports a study. Age, depression, disease duration, and the Expanded Disability Status Scale (EDSS) influence SF.
Examining the symptoms experienced by patients with postorgasmic illness syndrome (POIS) can help improve treatment and resolve these symptoms, suggests a study.
Proactive use of scheduled lorazepam or lorazepam plus haloperidol is superior to haloperidol alone in managing refractory agitated delirium in patients with advanced cancer in the palliative care setting, according to results of a multicentre randomized clinical trial (RCT) conducted in Taiwan and the US.
Patients with hidradenitis suppurativa (HS) face increased risks of depression and anxiety, as reported in a study.
